About the OSU College of Pharmacy: The College of Pharmacy prepares students of today to be the pharmacy practitioners and pharmaceutical sciences researchers of tomorrow by contributing to improved health, advancing patient care and the discovery and understanding of medicines.

Researchers take important step toward gonorrhea vaccine

Researchers are paving the way toward a new therapeutic approach for gonorrhea by shedding light on the mechanism behind important proteins on the Neisseria gonorrhoeae bacteria’s outer membrane. 

Nanoparticles developed at OSU show promise for locating, removing endometriosis lesions

PORTLAND, Ore. – Scientists have developed a new nanotechnology approach for locating and removing the painful and dangerous lesions associated with endometriosis, a common gynecological condition in women of childbearing age.

Oregon State University research suggests possibility of vaccine to prevent skin cancer

CORVALLIS, Ore. – Research by the Oregon State University College of Pharmacy suggests that a vaccine stimulating production of a protein critical to the skin’s antioxidant network could help people bolster their defenses against skin cancer.

Oregon State research shows hemp compounds prevent coronavirus from entering human cells

CORVALLIS, Ore. – Hemp compounds identified by Oregon State University research via a chemical screening technique invented at OSU show the ability to prevent the virus that causes COVID-19 from entering human cells.

Dietary fiber improves outcomes for melanoma patients on immunotherapy, research shows

CORVALLIS, Ore. – Melanoma patients receiving therapy that makes it easier for their immune system to kill cancer cells respond to treatment better when their diet is rich in fiber, according to a large, international research collaboration that includes the Oregon State University College of Pharmacy

Benefits of higher doses of certain medicines fail to justify costs and risks, study shows

Clinical trial data behind drug dose recommendations for elevated cholesterol and chronic obstructive pulmonary disease illustrate how larger doses may not be worth the extra costs for many types of patients, according to an Oregon State University College of Pharmacy researcher.

OSU researcher expands research into deadly muscle-wasting syndrome

An Oregon State University scientist has received a $2.3 million, five-year grant to build on his promising research into a debilitating muscle-wasting syndrome that kills as many as 30% of the cancer patients it afflicts.

Researchers reach milestone in use of nanoparticles to kill cancer with heat

Researchers at Oregon State University have developed an improved technique for using magnetic nanoclusters to kill hard-to-reach tumors.

OSU researcher to help lead $10.7 million push toward gonorrhea vaccine

An Oregon State University scientist is part of a $10.7 million National Institutes of Health grant to develop a vaccine for gonorrhea.

Gonorrhea researchers identify novel route to vaccine, new antibiotic

Researchers have identified a protein that powers the virulence of the bacteria that causes gonorrhea, opening the possibility of a new target for antibiotics and, even better, a vaccine.

Pages